Cellular immune responses to HTLV-I: Immunopathogenic role in HTLV-I- associated neurologic disease

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 13, Issue SUPPL. 1, 1996, Pages

  Jacobson, Steven ^a,b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b Neuroimmunology Branch   (United States)

Author keywords

Cytotoxic T lymphocyte; Disease association; HTLV I; Immunopathogenesis

Indexed keywords

CELLULAR IMMUNITY; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; NEUROLOGIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE;

HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0029781964     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199600001-00017     Document Type: Conference Paper

References (46)

1. McFarlin DE, Blattner WA. Non-AIDS retroviral infections in humans. Annu Rev Med 1991;42:97-105.
2. Osame M, Osuku K, Izumo S, et al. HTLV-I associated myelopathy: a new clinical entity. Lancet 1986;1:1031-2.
3. Uchiyama T, Yodoi J, Sagawa K, et al. Adult T cell leukemia clinical and hematologic features of 16 cases. Blood 1977;50:481-92.
4. Gessain A, Vernant JC, Maurs L, Barin F, Gout O, Calendar A, de The G. Antibodies to human T-lymphotropic virus I in patients with tropical spastic paraparesis. Lancet 1985;2: 407-10.
5. Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1989;1:441.
6. Sato K, Maruyama I, Maruyama Y, et al. Arthritis in patients infected with human lymphotropic virus type I: clinical and immunopathologic features. Arthritis Rheum 1991; 34:714-21.
7. Mochizuki M, Watanabe T, Yamaguchi K, et al. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res 1992;5:29-42.
8. Sugimoto M, Nakashima H, Watanabe S, et al. T lymphocyte alveolitis in HTLV-I-associated myelopathy. Lancet 1987;2:1220.
9. LeGrande K, Hanchard B, Fletcher V, Cranston B, Blatnner W. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet 1990;336:1345-7.
10. Kanazama H, Ijichi I, Eiraku N, et al. Behçet's syndrome and Sjögren syndrome in a patient with HTLV-I associated myelopathy. J Neural Sci 1993;119:121-2.
11. Usuku K, Sonada S, Osame M, et al. HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I associated myelopathy: comparison with adult T cell leukemia/ lymphoma. Ann Neurol 1988;23:S143-50.
12. Sonoda S, Fujiyoshi T, Yashiki S. Immunogenetics of HTLV-I associated diseases [Abstract]. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:242.
13. Daenke S, Nightingale S, Cruickshank JK, Bangham CR. Sequence variants of HTLV-I from patients with tropical spastic paraparesis and adult T cell leukemia do not distinguish neurological from leukemic isolates. J Virol 1990;64: 1278-82.
14. Nishimura M, McFarlin DE, Jacobson S. Sequence comparisons of HTLV-I from HAM/TSP patients and their spouses. Neurology 1993;43:2621-4.
15. Evangelista A, Minnegan H, Maroushek S, et al. Nucleotide sequence analysis of a provirus derived from an individual with spastic paraparesis. Microb Pathog 1990;8:259-78.
16. Renjifo B, Osterman J, Borrero I, Essex M. Nucleotide sequences of human T cell lymphotropic virus type I (HTLV-I) from a family cluster with tropical spastic paraparesis/ HTLV-I associated myelopathy. Res Virol 1995;146:93-9.
17. Mahieux R, de The G, Gessain A. The nucleotide tax mutation at position 7959 of HTLV-I is not associated with TSP/ HAM but is linked to the cosmopolitan molecular subtype [Abstract]. J Acquir Immune Def Syn Hum Retrovirol 1995; 10:283.
18. Kira J, Koyanagai Y, Yamada T, et al. Sequence heterogenity of HTLV-I proviral DNA in the central nervous system of patients with HTLV-I associated myelopathy. Ann Neurol 1994;36:149-56.
19. Saito M, Furukawa Y, Kubota R, et al. Frequent mutation in pX region of HTLV-I is observed in HAM/TSP patients, but is not specifically associated with the central nervous system lesions. J Neurovirol 1995;1:286-94.
20. Xu X, Kang SH, Heidenreich O, Brown DA, Nerenberg MI. HTLV-I associated myelopathy/tropical spastic paraparesis isolates bear mutations in the HTLV-I LTR R region which prevents binding of CREB and ATF-2 [Abstract]. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:217.
21. Jacobson S. Role of cellular immune responses in the pathogenesis of HTLV-I associated neurologic disease. In: Holsberg P, ed. Human T cell lymphotropic virus type I. London: John Wiley & Sons (in press).
22. Jacobson S, Gupta A, Mattson D, Mingioli E, McFarlin DE. Immunologic studies in tropical spastic paraparesis (TSP). Ann Neurol 1990;27:149-56.
23. Kitajima I, Osame M, Izumo S, Igata A. Immunological studies of HTLV-I associated myelopathy. Autoimmunity 1988;1:125-31.
24. Itoyama Y, Minato S, Kira J, et al. Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HAM. Neurology 1988;38:1302-7.
25. Kramer A, Jacobson S, Reuben JF, et al. Spontaneous lymphocyte proliferation is elevated in asymptomatic HTLV-I positive Jamaicans. Lancet 1989;8668:923-4.
26. Wiktor SZ, Jacobson S, Reuben JS, et al. Spontaneous lymphocyte proliferation in HTLV-II infected intravenous drug users. Lancet 1991;337:327-8.
27. Kira J, Koyanagi Y, Yamada T, et al. Increased HTLV-I proviral DNA in HAM: a quantitative polymerase chain reaction study. Ann Neurol 1991;29:194-201.
28. Kubota R, Fujiyoshi T, Izumo S, Yashiki S, Maruuyama I, Osame M, Sonoda S. Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I associated myelopathy. J Neuroimmunol 1993;42:147-54.
29. + HTLV-I specific cytotoxic T lymphocytes from patients with HAM/TSP: recognition of an immunogenic region of the gp46 envelope glycoprotein of HTLV-I. J Immunol 1991;146:1155-62.
30. Kannagi M, Matsushita S, Shida H, Harada S. Cytotoxic T cell response and expression of the target antigen in HTLV-I infection. Leukemia 1994;8(suppl 1):S54-9.
31. + cytotoxic lymphocytes specific for HTLV-I in patients with HTLV-I associated neurological disease. Nature 1990;348:245-8.
32. Jacobson S, McFarlin D, Robinson S, et al. Demonstration of HTLV-I specific cytotoxic T lymphocytes in the cerebrospinal fluid of patients with HTLV-I associated neurologic disease. Ann Neurol 1992;32:651-7.
33. Elovaara I, Koenig S, Brewah A, Jacobson S. High HTLV-I specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-I associated neurological disease. J Exp Med 1993;177:1567-73.
34. Koenig S, Woods R, Brewah AH, et al. Characterization of major histocompatibility complex-(MHC) class I restricted cytotoxic T cell (CTL) responses to Tax in HTLV-I infected patients with neurologic disease. J Immunol 1993;156:3874-83.
35. + cytotoxic T cells directed against HTLV-I infected cells. Int Immunol 1991;3:761-7.
36. Parker CE, Daenke S, Nightingale S, Bangham CR. Activated, HTLV-I specific cytotoxic T lymphocytes are found in healthy seropositives as well as patients with tropical spastic paraparesis. Virology 1992;188:628-36.
37. Daenke S, Kermode AG, Hall SE, et al. High cytotoxic effector frequencies occur in healthy HTLV-I carriers and patients with tropical spastic paraparesis [Abstract]. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:243.
38. Moore GRW, Traugott U, Scheinberg LC, Raine CS. TSP: a model of virus-induced cytotoxic T-cell mediated demyelination? Ann Neurol 1989;26:523-30.
39. Iwasaki I. Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP). J Neurol Sci 1990;96:103-23.
40. Yoshioka A, Hirose G, Ueda Y, Nishimura Y, Sakai K. Neuropathological studies of the spinal cord in early stage HTLV-I associated myelopathy (HAM). J Neurol Neurosurg Psychiatry 1993;56:1004-7.
41. + lymphocytes in the spinal cord from patients with HTLV-I associated myelopathy. J Neuroimmunol 1994;43:23-9.
42. Lehky TJ, Fox CH, Koenig S, et al. Detection of human T lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HAM/TSP by in situ hybridization. Ann Neurol 1995;37:246-54.
43. Kuroda Y, Matsui M, Kikuchi M, et al. In situ demonstration of the HTLV-I genome in the spinal cord of a patient with HTLV-I associated myelopathy. Neurology 1994;44: 2295-9.
44. Hara H, Mortia M, Iwaki T, et al. Detection of HTLV-I proviral DNA and analysis of T cells receptor Vβ CDR3 sequences in spinal cord lesions in HAM/TSP. J Exp Med 1994;180:831-9.
45. Kitijima I, Yamamoto K, Sato K, et al. Detection of HTLV-I proviral DNA and its gene expression in synovial cells in chronic inflammatory arthropathy. J Clin Invest 1991;88: 1315-22.
46. Yamazaki H, Ikeda H, Ishizu A, et al. HTLV-I env-pX transgenic rats: prototype animal model for collagen vascular diseases [Abstract]. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:270.